Position in NVS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,958,686
+$38,924 QoQ
Shares Held
12,498
-0.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
#437
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ROBERTS GLORE & CO INC /IL/ holds $30,036,472 across 10 Drug Manufacturers - General names. NVS ranks #4 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
49,900 | $12,673,103 | |
| 2 | ABBV |
AbbVie Inc.
|
29,453 | $7,411,552 | |
| 3 | AMGN |
Amgen Inc
|
6,771 | $2,451,914 | |
| 4 | NVS |
Novartis AG
This page
|
12,498 | $1,958,686 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
9,885 | $1,248,870 | |
| 6 | NVO |
Novo Nordisk A S
|
25,727 | $1,233,352 | |
| 7 | PFE |
Pfizer Inc
|
39,351 | $947,572 | |
| 8 | MRK |
Merck & Co., Inc.
|
6,037 | $775,754 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,958,686 | 12,498 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,919,762 | 12,568 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $1,761,013 | 12,773 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $1,685,458 | 13,143 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,634,603 | 13,508 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,576,215 | 14,139 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $1,375,866 | 14,139 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $1,648,696 | 14,334 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,564,003 | 14,691 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,445,436 | 14,943 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,568,165 | 15,531 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,698,617 | 16,676 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,708,002 | 16,926 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,560,504 | 16,962 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $1,547,864 | 17,062 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,267,998 | 16,682 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $1,410,129 | 16,682 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,454,017 | 16,570 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $1,440,630 | 16,470 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,382,327 | 16,903 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,537,667 | 16,853 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,449,142 | 16,953 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $1,625,612 | 17,215 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $1,498,929 | 17,237 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $1,507,226 | 17,257 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,464,064 | 17,757 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||